Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Epzicom receives FDA approval

Aug. 4, 2004

Accelerated approval for Truvada

Aug. 4, 2004

GenVec and NIAID advance HIV vaccine into clinical testing

Aug. 2, 2004

Abbott seeks approval of once-daily Kaletra in U.S., E.U.

July 29, 2004

HIV-1 integrase inhibitor promising against resistant viral strains

July 29, 2004

Results of Chinese study of VGV-1 in HIV patients

July 28, 2004

Assessment of the pharmacokinetics and pharmacodynamics of UK-427857

July 27, 2004

Boehringer Ingelheim discloses anti-HIV agents

July 26, 2004

Several drugs show efficacy in the treatment of HIV-associated lipodystrophy

July 26, 2004

Novel class of HIV-1 entry inhibitors targets gp120-binding domain of CD4

July 26, 2004

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...